CV Stock Analysis: Buy, Sell, or Hold?
CV - CapsoVision, Inc. Common Stock
$5.02
-0.40 (-7.38%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
10d
Get Alerted When CV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CV is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CV is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CV is currently trading at $5.02, which is considered oversold relative to its 30-day fair value range of $5.81 to $11.57.
Technical Outlook: Technically, CV is in a uptrend. The price is currently testing key support at $4.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: CV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.00 (+19.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CV is in a uptrend. The price is currently testing key support at $4.89. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: CV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.00 (+19.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.81 -
$11.57
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
44.7%
Protect Your Profits
Holding CV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-7.4%)
- BULLISH: Trading below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$5.81 -
$11.57
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.89
Resistance Level
$7.12
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.91
Wall Street Target
$6.00
(+19.5%)
Revenue Growth (YoY)
16.6%
Profit Margin
-163.3%
Last updated: February 01, 2026 11:14 AM ET
Data refreshes hourly during market hours. Next update: 12:14 PM
Data refreshes hourly during market hours. Next update: 12:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CV showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced CV Option Strategies
Professional options setups generated by AI based on today's CV price and gamma walls.